US regulator alleges Dr Reddy's breached packaging rules

Tags: Companies
Export-focused drugmaker Dr Reddy's Laboratories Ltd said it was in talks with a US regulator over allegations it violated packaging rules for some prescription drugs sold there between 2008 and 2012.

The allegations by the U.S. government's Consumer Product Safety Commission (CPSC) are the latest in a series of regulatory troubles facing Indian pharmaceutical firms in their biggest export market, the United States.

In a U.S. stock exchange filing this week, Dr Reddy's said the CPSC planned to seek civil penalties against the company for allegedly violating rules intended to prevent children from ingesting harmful substances.

The company said any unfavourable outcome could result in "significant liabilities" and added that it disagreed with the allegations.

Indian drugmakers have suffered a string of drug recalls and manufacturing quality-related issues that have hurt the reputation of the $15 billion-a-year industry as a supplier of cheap generic drugs, and led to increased scrutiny from regulators.

EDITORIAL OF THE DAY

  • Stricter deterrent must to force defiant promoters to buy back shares

    The Securities and Exchange Board of India’s (Sebi’s) decision to delist companies that have been suspended from trading on stock exchanges for mo

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Amita Sharma

Political rhetoric makes for counter poetry

Poetic flourishes flavour politics. Ghalib and Hafez flowed profusely to ...

Zehra Naqvi

Watch your words, for they can kill

You must’ve heard the ph­rase ‘if looks could kill’. Ever ...

Dharmendra Khandal

Biodiversity day has come and gone. Yet again

Every year on May 22, world celebrates international biodiversity day. ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture